High-Dose Moxalactam in Gram-Negative Pneumonia

Abstract

Get full access to this article

View all access options for this article.

References

Kammer

. Moxalactam: Clinical summary of efficacy and safety. Rev Infect Dis 1982; 4 (suppl): S712–9.

Perlino

. Moxalactam therapy for bacterial pneumonia. Rev Infect Dis 1982; 4 (suppl): S617–22.

Saito

. Clinical evaluation of moxalactam in the treatment of respiratory tract infections, hepatobiliary infections, and septicemia. Rev Infect Dis 1982; 4 (suppl): S623–8.

Salzer

Pegram

Jr McCall

. Clinical evaluation of moxalactam: Evidence of decreased efficacy in gram-positive aerobic infections. Antimicrob Agents Chemother 1983; 23: 565–70.

Lentino

Rytel

Moore

. Therapy of lower respiratory tract infections with moxalactam. Antimicrob Agents Chemother 1981; 19: 801–6.

Winston

Busuttil

Kurtz

Young

. Moxalactam therapy for bacterial infections. Arch Intern Med 1981; 141: 1607–12.

Cipolle

Seifert

Zakse

Strate

. Hospital acquired gram-negative pneumonias: Response rate and dosage requirements with individualized tobramycin therapy. Therapeut Drug Monit 1980; 2: 359–63.